Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Intrathecal Versus Intravenous Dexmedetomidine Adjuvant to Bupivacaine in Elective Cesarian Section

NCT06410365 is registered in ClinicalTrials.gov with Muhammad Ilyas as lead sponsor.

NCT NCT06410365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06410365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Intrathecal Versus Intravenous Dexmedetomidine Adjuvant to Bupivacaine in Elective Cesarian Section
Lead sponsor
Muhammad Ilyas
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2024
Completion date
December 31, 2024
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nausea and vomiting, postoperative